| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | Bortezomib | GDSC1000 | pan-cancer | AAC | -0.0025 | 1 |
| mRNA | BRD-K48477130 | CTRPv2 | pan-cancer | AAC | 0.0029 | 1 |
| mRNA | ML006 | CTRPv2 | pan-cancer | AAC | -0.0019 | 1 |
| mRNA | paclitaxel | GDSC1000 | pan-cancer | AAC | 0.0025 | 1 |
| mRNA | BRD-K02492147 | CTRPv2 | pan-cancer | AAC | 0.002 | 1 |
| mRNA | tamatinib | CTRPv2 | pan-cancer | AAC | 0.0018 | 1 |
| mRNA | PLX4720 | GDSC1000 | pan-cancer | AAC | -0.0013 | 1 |
| mRNA | LRRK2-IN-1 | CTRPv2 | pan-cancer | AAC | 0.0016 | 1 |
| mRNA | ML210 | CTRPv2 | pan-cancer | AAC | -0.0014 | 1 |
| mRNA | CIL41 | CTRPv2 | pan-cancer | AAC | -0.0022 | 1 |